合作客户/
拜耳公司 |
同济大学 |
联合大学 |
美国保洁 |
美国强生 |
瑞士罗氏 |
相关新闻Info
-
> 中性聚合物键合剂(NPBA)与奥克托今(HMX)界面张力测定及应用效果(三)
> 表面张力仪与界面张力仪的区别
> 改性环氧树脂乳液型碳纤维上浆剂制备、表面张力、黏度等性能测试(二)
> 生活中存在的一些表面张力现象
> 接触角迟滞时气~液界面张力的温度敏感性对液滴蒸发过程的影响——引言
> 酯官能化酰胺型双子表面活性剂的制备与性能研究
> 不同表面张力温度系数对激光焊接熔池流场的影响
> 新研究的海水基耐高温驱油压裂液界面张力值等性能优于常规驱油压裂液产品
> 定性分析聚合物界面张力与系统黏度比之间的关系——数值模拟、实验研究结果
> Wilhelmy吊板法测试温度、铝元素和稀土元素对锌浴表面张力的影响
推荐新闻Info
Delta-8 动物胃肠道体内中药物的溶解度的测定——结论、工具书类!
来源:上海谓载 浏览 1563 次 发布时间:2021-11-26
结论
胃肠道pH值和缓冲容量的种间差异是重要的考虑因素,尤其是对胃肠道给药的pHresponsive配方和可电离药物。 因此,兔子和猪的空肠、回肠和近端结肠具有相对较高的缓冲容量,而猪远端结肠具有较低的缓冲容量是非常重要的考虑因素。 与人相比,大鼠、兔和猪的近端小肠和升结肠的液体的渗透压和表面张力也较高。 胃肠道特征的这些差异导致泼尼松龙在大鼠体内的溶解度较高(近端结肠除外),而泼尼松龙在猪和兔体内的溶解度与人类相当。 因此,如果在大鼠的体液中测量,中性化合物泼尼松龙的溶解度可能被高估。 另一方面,可电离药物美沙拉秦在兔和猪体内的溶解度在小肠中部高于人,在结肠中低于人,仅在小肠远端与人相当。 胃肠道环境的差异,如pH值、缓冲容量、渗透压和表面张力,导致药物溶解度的差异。 在兔子和猪中,美沙拉秦的溶解度在沿胃肠道向下移动时发生显著变化,这在很大程度上受管腔液的pH值和渗透压的影响。
工具书类
1. Flaisher-Grinberg S et al. Models of mania: from facets to domains and from animal models to model animals. J Psychopharmacol 2010; 24: 437–438.
2. Insel TR. From animal models to model animals. Biol Psychiatry 2007; 62: 1337–1339.
3. Hannah-Poquette C et al. Modeling mania: further validation for Black Swiss mice as model animals. Behav Brain Res 2011; 223: 222–226.
4. Calabrese EJ. Gastrointestinal and dermal absorption – interspecies differences. Drug Metab Rev 1984; 15: 1013–1032.
5. Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory-animals. Biopharm Drug Dispos 1995; 16: 351–380.
6. McConnell EL et al. Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments. J Pharm Pharmacol 2008; 60: 63–70.
7. Ward FW, Coates ME. Gastrointestinal pH measurement in rats: influence of the microbial flora, diet and fasting. Lab Anim 1987; 21: 216–222.
8. Smith HW. Observations on the Flora of the alimentary tract of animals and factors affecting its composition. J Pathol Bacteriol 1965; 89: 95–122.
9. Clarysse S et al. Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states. J Pharm Sci 2009; 98: 1177–1192.
10. Kalantzi L et al. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res 2006; 23: 165–176.
11. Fadda HM et al. Drug solubility in luminal fluids from different regions of the small and large intestine of humans. Mol Pharm 2010; 7: 1527– 1532.
12. Merchant HA et al. Assessment of gastrointestinal pH, fluid and lymphoid tissue in the guinea pig, rabbit and pig, and implications for their use in drug development. Eur J Pharm Sci 2011; 42: 3–10.
13. ToxNet. Mesalamine: Toxicology data network (ToxNet). US National Library of Medicine, CASRN: 89-57-6. 2014. (http://toxnet.nlm.nih.gov/cgi-bin/sis/ search2/r?dbs+hsdb:@term+@rn+@ rel+89-57-6, last accessed 25th June 2014).
14. Machatha SG, Yalkowsky SH. Comparison of the octanol/water partition coefficients calculated by ClogP, ACDlogP and KowWin to experimentally determined values. Int J Pharm 2005; 294: 185–192.
15. McConnell EL et al. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm 2008; 364: 213–226.
16. Mudie DM et al. Physiological parameters for oral delivery and in vitro testing. Mol Pharm 2010; 7: 1388– 1405.
17. French DL, Mauger JW. Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery. Pharm Res 1993; 10: 1285–1290.
18. Perez de la Cruz Moreno M et al. Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum. J Pharm Pharmacol 2006; 58: 1079–1089. 19. Diakidou A et al. Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults. Pharm Res 2009; 26: 2141–2151.
Delta-8 动物胃肠道体内中药物的溶解度的测定——摘要、介绍
Delta-8 动物胃肠道体内中药物的溶解度的测定——材料和方法